Evaluation of a Child with Elevated Transaminases. Linda V. Muir, M.D. April 11, 2008 Northwest Pediatric Liver Disease Symposium



Similar documents
Evaluation of abnormal LFT in the asymptomatic patient. Son Do, M.D. Advanced Gastroenterology Vancouver, WA

The child with abnormal liver function tests

Evaluation of Liver Function tests in Primary Care. Abid Suddle Institute of Liver Studies, KCH

Approach to Abnormal Liver Tests

Patterns of abnormal LFTs and their differential diagnosis

Albumin. Prothrombin time. Total protein

Hepatitis C. Laboratory Tests and Hepatitis C

OMG my LFT s! How to Interpret and Use Them. OMG my LFT s! OMG my LFT s!

What to do with abnormal LFTs? Andrew M Smith Hepatobiliary Surgeon

Review: How to work up your patient with Hepatitis C

Disclosures. Interpreting Liver Tests: What Do They Mean? Liver Function Tests. Objectives. Common Tests. Case 1

Adams Memorial Hospital Decatur, Indiana EXPLANATION OF LABORATORY TESTS

Abnormal Liver Tests. Dr David Scott Gastroenterologist

Abnormal LFT s in Asymptomatic Patients

Managing LFT s in General Practice

Transmission of HCV in the United States (CDC estimate)

Alanine aminotransferase (serum, plasma)

Protein electrophoresis is used to categorize globulins into the following four categories:

2.1 AST can be measured in heparin plasma or serum. 3 Summary of clinical applications and limitations of measurements

Southern Derbyshire. Shared Care Pathology Guidelines. Abnormal Liver Function Tests (LFTs) in Adults

Drugs Believed Capable of Inducing Autoimmune Hepatitis

Asymptomatic Elevated Liver Function Tests: Physiology, Chemistry, and Workup

1.5 Function of analyte For albumin, see separate entry. The immunoglobulins are components of the humoral arm of the immune system.

CMS Limitations Guide - Laboratory Services

LCD for Viral Hepatitis Serology Tests

Prof. of Tropical Medicine Faculty of Medicine Alexandria University

INITIATING ORAL AUBAGIO (teriflunomide) THERAPY

LIVER FUNCTION TESTS

Routine Investigations for Liver Disease a guide

Liver Function Tests. Dr Stephen Butler Paediatric Advance Trainee TDHB

LIVER FUNCTION TESTS

Liver Function Tests - The Downside

The following should be current within the past 6 months:

HOW TO EVALUATE ELEVATED LIVER ENZYMES

EXECUTIVE BLOOD WORK PANEL

Evaluation and Prognosis of Patients with Cirrhosis

Bile Duct Diseases and Problems

Hepatitis C Treatment Expansion Initiative Multi-Site Conference Call. March 16, 2011

HEPATOLOGY CLERKSHIP

MANAGEMENT OF COMMON SIDE EFFECTS of INH (Isoniazid), RIF (Rifampin), PZA (Pyrazinamide), and EMB (Ethambutol)

Blood Testing Protocols. Disclaimer

BASIC INFORMATION ABOUT HIV, HEPATITIS B and C, and TUBERCULOSIS Adapted from the CDC

Liver Diseases. An Essential Guide for Nurses and Health Care Professionals

Hepatitis Panel/Acute Hepatitis Panel

understanding CIRRHOSIS of the liver A patient s guide from your doctor and

Alcoholic Hepatitis (Teacher s Guide)

GUIDELINES & PROTOCOLS

New Development in Treating Liver Disorders: Approaches to liver function test from mild to fulminant disorders

NUTRITION IN LIVER DISEASES

Collect and label sample according to standard protocols. Gently invert tube 8-10 times immediately after draw. DO NOT SHAKE. Do not centrifuge.

Pediatric Latent TB Diagnosis and Treatment

Session 11: The ABCs of LFTs Learning Objectives

Revised Newcastle, North Tyneside and Northumberland Guidelines for the Management of Adults with Asymptomatic Liver Function Abnormalities.

U.S. Food and Drug Administration

2015 Outpatient Chronic Hepatitis B Management

Liver Function Essay

Laboratory Monitoring of Adult Hospital Patients Receiving Parenteral Nutrition

What to Do with the Patient With Abnormal Liver Enzymes? Nizar N. Zein, M.D. The Cleveland Clinic

Interpretation of Laboratory Values

Update on Hepatitis C. Sally Williams MD

LIVER FUNCTION TESTS AND LIVER DISEASES. Prof. Fang Zheng Department of Laboratory Medicine School of Medicine, Wuhan University

Hepatitis C treatment What to expect.

Liver Test Pearls- What s New?

Cirrhosis and Ascites. Thomas S. Foster, Pharm.D. Integrated Therapeutics PHR 961

HEPATITIS C. The Facts. Get Tested. Get Cured! Health

NP/PA Clinical Hepatology Fellowship Summary of Year-Long Curriculum

Non-alcoholic fatty liver disease: Prognosis and Treatment

Commonly Asked Questions About Chronic Hepatitis C

Fast Facts. Fast Facts: Liver Disorders. Thomas Mahl and John O Grady Health Press Ltd.

Assessment of some biochemical tests in liver diseases

Alpha-fetoprotein

Canadian Association of Gastroenterology (CAG) Practice Guidelines: Evaluation of abnormal liver enzyme tests

LAB 1 - Direct agglutination. Serology-the study of the in vitro reactions between antibody and antigen

Testing for RA. The Ideal Lab Test. William M. Wason, MD, PhD 9/24/2010. Confusion Abounds

Presents: Insider tips for the life insurance medical exam. Know what they are testing for--and how to get the best results.

Approach to Abnormal Liver Tests

Rheumatology Labs for Primary Care Providers. Robert Monger, M.D., F.A.C.P Frontiers in Medicine

Systemic Lupus Erythematosus

A.P. Chen, MD Director, Developmental Therapeutics Clinic Division of Cancer Treatment and Diagnosis National Cancer Institute

ABNORMAL LIVER ENZYMES: A PRACTICAL CLINICAL APPROACH. David C. Twedt, DVM, Diplomate ACVIM Colorado State University twedt@colostate.

Lupus in Children and Teenagers. Arielle Hay, MD Pediatric Rheumatologist Nicklaus Children s Hospital

Disclosures. Consultant and Speaker for Biogen Idec, TEVA Neuroscience, EMD Serrono, Mallinckrodt, Novartis, Genzyme, Accorda Therapeutics

How To Treat Hepatitis C

Abnormal Liver Tests: work-up and diagnosis

PAUL T. GIBONEY, M.D., Keck School of Medicine, University of Southern California, Los Angeles, California

Aubagio. Aubagio (teriflunomide) Description

FURTHER EXPERIENCE WITH SUBCUTANEOUS IMMUNOGLOBULIN THERAPY IN CHILDREN WITH PRIMARY IMMUNE DEFICIENCIES

Determining Donor Eligibility Blood Donor vs. Stem Cell Donor. Wanda Koetz, RN, HPC Clinical Nurse Lead, Memorial Blood Centers ASFA - May 7, 2015

San Francisco Treatment Guidelines for Latent Tuberculosis Infection

Assessment of Liver Function and Diagnostic Studies. Disclosures

National Digestive Diseases Information Clearinghouse

MANAGEMENT OF TUBERCULOSIS

Acute Pancreatitis. Questionnaire. if yes: amount (cigarettes/day): since when (year): Drug consumption: yes / no if yes: type of drug:. amount:.

MONONUCLEOSIS AND ATHLETICS:

KEY CHAPTER 14: BLOOD OBJECTIVES. 1. Describe blood according to its tissue type and major functions.

THE THE LIVER. Assessing the Silent Progress of Liver Disease

Provided by the American Venous Forum: veinforum.org

Rheumatoid Arthritis. Nicole Klett,, M.D.

BCCA Protocol Summary for Palliative Treatment of Advanced Pancreatic Neuroendocrine Tumours using SUNItinib (SUTENT )

You, Your Liver and Alpha-1. Skinny Little Reference Guide

Transcription:

Evaluation of a Child with Elevated Transaminases Linda V. Muir, M.D. April 11, 2008 Northwest Pediatric Liver Disease Symposium

Disclosures I do not have a financial interest, arrangement or affiliation with medical/pharmaceutical/equipment companies.

Liver Function Tests Liver cell injury or inflammation AST, ALT, LDH Synthetic function PT, PTT, INR, Albumin, clotting factors VII & V Bile flow or cholestasis GGT and alkaline phosphatase, plus 5 nucleotidase Hepatic excretory function Bilirubin, serum bile acids

Case Study 17 year old male presented with 3 week history of fatigue, no jaundice, nausea, and malaise. Evaluation by his primary careprovider revealed normal bilirubin, but elevated transaminases in the 900-1100 iu range. PT and INR were normal as was GGT

History Previously well, excellent student Dropped back in athletics due to fatigue Few pounds of wt loss attributed to poor appetite No family history of liver disease No exposures such as prior transfusions or travel outside the US Denied use of IV drugs No chronic medications or herbal use

Evaluation- Physical Physical exam Normal vitals Mildly icteric Normal body habitus; no sign of chronicity No K-F rings Liver edge down 1.5 cm below RCM, normal texture, slightly tender; no splenomegaly No skin lesions

Evaluation Initial Laboratory CBC without anemia or evidence of hemolysis Platelets slightly elevated AST 900, ALT 1100 Total protein 8.9, albumin 3.1 PT and INR normal Alkaline phos & GGT were normal Bilirubin total and direct slightly elevated

Evaluation Imaging Liver slightly enlarged for age, homogeneous and normal appearing texture Doppler of hepatic vessels was normal Spleen no abnormality seen

Evaluation Further Labs Serum copper and ceruloplasmin were normal Alpha 1- antitrypsin phenotype MM Viral screen was negative for hep A, B, C EBV titers showed past infection CMV screen negative No hx of URI to warrant nasal swab Tylenol level normal Anti-bodies for LKM (liver, kidney microsomes) were normal, as was celiac screen Smooth muscle antibodies: 1:320 IgG total was 2 times normal

Biopsy of Liver Many plasma cells & mononuclear cells Active hepatitis extending beyond the limiting plate No bridging fibrosis No viral inclusions seen No evidence of metabolic disorders

Therapy Immunosuppression Close monitoring Protection from future hepatic infections

Differential Diagnoses Autoimmune disorders Viral - hepatitis A, B, C, EBV, CMV Adenovirus, coxsackie, varicella, HSV, HIV Metabolic alpha 1- antitrypsin, Wilson s Toxins Tylenol, herbals, minocycline Non- alcoholic steatohepatitis (NASH) Vaccination induced - Synergis

Autoimmune hepatitis Two main types Type I or classic with antibodies to smooth muscle Type II with antibodies to liver-kidney microsomes Third type with antibodies against soluble liver antigens has been proposed Some consider this as subset of AIH-I. There is also overlapping syndrome between AIH and sclerosing cholangitis.

Other Autoimmune Disorders -> Elevated Liver Transaminases Celiac disease Rheumatoid arthritis Inflammatory bowel disease Systemic lupus erythematosus Thyroiditis

Case II 12 year old boy presents to peds gi clinic with jaundice, weight loss, fatigue, intermittent fevers No family history of liver disease No unusual exposures travel, meds, toxins, IV drugs, herbals or tattoos

Laboratory Evaluation Total an direct bilirubin mildly elevated High GGT and alkaline phosphatase Normal IgG total and antibody studies Normal coagulation studies Transaminases slightly elevated CBC notable for slight anemia Normal serum copper and ceruloplasmin Normal alpha1- antitrypsin phenotype Viral studies all negative, no prodrome

Evaluation- Physical Thin, small in height for age, and low wt for ht. Jaundiced Mildly tender over the RUQ and RLQ, no hepatosplenomegaly; no fluid wave No spider telangectasias

Further Evaluation Imaging- no hepatosplenomegaly by ultrasound, and normal vessel flow. No ductal obstruction or dilatation Liver biopsy neutrophils in ductules, with profound expansion in the portal triads. No fibrosis.

Endoscopy and Colonoscopy Severe inflammation in the terminal ileum Biopsies confirmed Crohn s disease

Therapy Treated for inflammatory bowel disease with steroids, Imuran and Pentasa Treated for bacterial cholangitis with antibiotics

Case III 8 year old hospitalized for malaise, nausea Found to have elevated AST and AST in 3000 range, mildly elevated bilirubin Coagulopathy No family hx of liver disease

History tells all Medication 2 months into therapy for TB INH Rifampicin Streptomycin Resolved with supportive care and modification of TB medication regimen

Evaluating Child with Elevated Transaminases History is critical for exposures Medications Herbals Travel Drug abuse Tattoos

Obtain clear medication history Chronic Tylenol, especially if taking other medication such as phenytoin Minocycline/erythromycin Isoniazid esp when taken with rifampicin, streptomycin or ethambutal Vitamin A in excess Herbals bush teas, comfrey,(alkaloids), kava kava, chaparral leaf, echinacea has some hepatotoxic potential.

Screening Priorities Viral- hepatitis A, B, C, CMV, EBV titers Other viral studies as warranted, HSV, adenovirus, HIV Autoimmune total IgG, antibodies to smooth muscle & LKM, IgA total & TTG Metabolic- Alpha 1- AT phenotype, ceruloplasmin & serum copper Toxin/medication- Tylenol level Ultrasound